Quality Study of Anesthetic Technique on Breast Cancer Surgery
NCT ID: NCT01499836
Last Updated: 2014-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
101 participants
INTERVENTIONAL
2012-01-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pectoralis Nerve Block and Quality of Recovery in Mastectomy Patients
NCT05266378
Reducing Pain and Disability After Breast Cancer Surgery
NCT01089933
Nerve Block Versus Non-targeted Local Anaesthesia in Breast Surgery
NCT02410746
The Effect of Thoracal Paravertebral Block on Seroma Reduction in Breast Surgery
NCT03650868
Paravertebral Block (PVB) Combined Pectoral Musculature Blocks for Modified Radical Mastectomy (MRM)
NCT02747992
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
general anesthesia and PVB
general anesthetics consisting of propofol, cisatracurium and fentanyl for endotracheal intubation and deaflurane for maintenance will be given. After intubation, paravertebral injections will be performed under ultrasound guidance.
PVB
paravertebral block
sedation and PVB
After sedation with midazolam and fentanyl, the patients in sedation and PVB group will receive PVB. paravertebral injections will be performed under ultrasound guidance.Intraoperative sedation will be provided with propofol titrated to moderate sedation.
PVB
paravertebral block
general anesthesia
general anesthetics consisting of propofol, cisatracurium and fentanyl for endotracheal intubation and deaflurane for maintenance will be given.
PVB
paravertebral block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PVB
paravertebral block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female
* 18 - 70 years of age
* Patients able to read a newspaper in Chinese.
* Elective unilateral wide excision/simple mastectomy and SLNB/ALND
* Patient has signed an informed consent
* Without contraindication of GA or PVB
* Body mass index (BMI) less than 24 kg/m2
Exclusion Criteria
* inability to provide informed consent
* Bleeding disorders
* Contraindications to nonsteroidal anti-inflammatory drugs (NSAIDs)
* Allergy to amide-type local anesthetics or NSAIDs
* Infection at the thoracic paravertebral injection site
* Pregnancy or breast-feeding
* Severe spine or chest wall deformity
* body mass index equal to or more than 24 kg/m2
* patients with major psychosis or drug and alcohol abuse
* patients with a history of significant neurological, psychiatric, neuromuscular, cardiovascular, pulmonary, renal or hepatic disease
* Patients with significant visual impairment or other physical disability that precludes complete cooperation
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nai Liang Li
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nai Liang Li
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nai Liang Li
Role: PRINCIPAL_INVESTIGATOR
Koo Foundation Sun Yat-Sen Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Koo Foundation Sun Yat-Sen Cancer Center
Taipei, Taiwan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20110920A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.